The first image of a black hole, which captivated the world in 2019, has received a remarkable upgrade thanks to the application of artificial intelligence (AI). A research team utilized AI algorithms to enhance the initial image, resulting in a sharper depiction that showcases the black hole at the center of the M87 galaxy as darker and larger than before.

AI has been an integral part of astronomy for decades, with astronomers harnessing its power to study galaxies and explore cosmology. In 1990, researchers from the University of Arizona pioneered the use of neural networks, a form of AI, to analyze galaxy shapes. Since then, AI has permeated every aspect of astronomy, helping scientists navigate vast data sets and uncover new insights about the universe.

Throughout the history of astronomy, understanding the multitude of celestial objects has been a complex endeavor. The advancements in telescopes have led to a tremendous increase in the number of observable celestial entities, resulting in exponential growth in data volume. For instance, the forthcoming Vera Rubin Observatory in Chile is expected to generate an astonishing 0.5 exabytes of data over a decade, equivalent to around 50,000 times the information stored in the Library of Congress.

VeriSIM Life, a pioneering company in the field of artificial intelligence, has harnessed the power of digital twins and machine intelligence to revolutionize pharmaceutical testing. By creating digital replicas of various human body types and animal models, VeriSIM can predict the impact of pharmaceuticals on real-life subjects before even entering clinical trials, significantly reducing time, costs, and risks associated with drug development.

Founded in 2017 by Dr. Jo Varshney, a veterinarian with expertise in genomics and cancer biology, VeriSIM collaborates with pharmaceutical companies, biotech firms, and academic institutions to assess the efficacy and safety of medications using AI simulations instead of animal testing. This approach addresses the common challenge in drug development, as approximately 89% of drugs that pass animal testing fail in human trials.

Since the advent of OpenAI’s ChatGPT, an AI language model that provides human-like responses, the world has witnessed a heightened focus on advanced technology. The business sector, in particular, has become a battleground, with Microsoft’s significant investment of $10 billion in OpenAI and the integration of OpenAI tools into its Bing search engine, aiming to compete with Google.

AI’s influence, however, extends beyond commerce and permeates various fields, including geopolitics. The growing significance of AI intersects with the escalating tensions between global powers, particularly the United States and China, as well as the global movement against globalization. This convergence creates a new and potentially less stable geopolitical environment, impacting both political and military domains.

In a groundbreaking development, researchers have harnessed the potential of GPT1, the precursor to the AI chatbot ChatGPT, to translate MRI imagery into text, providing insights into an individual’s thoughts. This breakthrough, achieved by scientists at the University of Texas at Austin, allows for the continuous flow of text to represent a person’s thoughts based on their auditory experiences, imagination, or visual stimuli.

While this advancement in mind-reading technology brings new possibilities, it also raises profound concerns regarding privacy, freedom of thought, and the unhindered freedom to dream. Existing laws are ill-prepared to handle the widespread commercial use of such technology, as freedom of speech laws do not extend to safeguarding our inner thoughts.